COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
The Lancet Oncology,
Superior therapy response predictions for patients with acute myeloid leukemia (AML) using Cellworks Singula: MyCare-009-01
ASCO Meeting Library,
Superior therapy response predictions for patients with myelodysplastic syndrome (MDS) using Cellworks Singula: MyCare-009-02
ASCO Meeting Library,
Superior therapy response predictions for patients with glioblastoma (GBM) using Cellworks Singula: MyCare-009-03
ASCO Meeting Library,
Superior therapy response predictions for patients with low-grade glioma (LGG) using Cellworks Singula: MyCare-009-04
ASCO Meeting Library,
Superior therapy response predictions for patients with pancreatic cancer (PDAC) using Cellworks Singula: MyCare-009-05
ASCO Meeting Library,
Combination chemotherapy versus temozolomide (TMZ) for patients with MGMT methylated (m-MGMT) glioblastoma (GBM): Results of cellworks omics biosimulation—myCare-015
ASCO Meeting Library,
Prediction of Outcomes With a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated With Radiation Therapy and Temozolomide